Juvenile myoclonic epilepsy

MONDO:0009696

The most common hereditary idiopathic generalized epilepsy syndrome and is characterized by myoclonic jerks of the upper limbs on awakening, generalized tonic-clonic seizures manifesting during adolescence and triggered by sleep deprivation, alcohol intake, and cognitive activities, and typical absence seizures (30% of cases).

Also known as: EJM, JME, epilepsy, myoclonic juvenile, juvenile myoclonus epilepsy, myoclonic epilepsy, juvenile, myoclonic epilepsy, juvenile, 1, myoclonic epilepsy, juvenile, susceptibility to, 1, petit mal, impulsive

10 clinical trials for this condition and its sub-types, 3 tagged with Juvenile myoclonic epilepsy itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Variable-age onset idiopathic generalized epilepsy syndrome (17) ↑ Myoclonic epilepsy (16)

Sub-types of Juvenile myoclonic epilepsy

Myoclonic epilepsy, juvenile, 2 0 trials

Including sub-types (10) Tagged with Juvenile myoclonic epilepsy (3)

Trials to join now! 1 Not yet recruiting 1 Terminated 1

Can a new drug cut seizure days in juvenile myoclonic epilepsy?

Disease control Not yet recruiting

This trial tests whether an experimental drug called JZP926 can safely reduce the number of days people aged 10 and older experience myoclonic seizures—brief, shock-like jerks—due to juvenile myoclonic epilepsy. Participants are randomly assigned to receive either JZP926 or a pla…

Phase 2/3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC

Juvenile myoclonic epilepsy

Where it sits in the disease tree

Can a new drug cut seizure days in juvenile myoclonic epilepsy?